Cargando…
Self-efficacy and self-management strategies in acute intermittent porphyria
BACKGROUND: Acute intermittent porphyria (AIP) is an inherited metabolic disease with low clinical penetrance caused by mutations in the hydroxymethylbilane (HMBS) gene. Although most patients experience little or no symptoms, serious attacks may include excruciating pain, severe electrolyte disturb...
Autores principales: | Hammersland, Marte H., Aarsand, Aasne K., Sandberg, Sverre, Andersen, Janice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607542/ https://www.ncbi.nlm.nih.gov/pubmed/31269991 http://dx.doi.org/10.1186/s12913-019-4285-9 |
Ejemplares similares
-
Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study
por: Andersen, Janice, et al.
Publicado: (2020) -
Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators
por: Bustad, Helene J., et al.
Publicado: (2021) -
Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2020) -
Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study
por: Tollånes, Mette Christophersen, et al.
Publicado: (2010) -
Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2019)